⚡ This is your brand? Claim your page free and bring it to life on AI search.
EOHILIA™
About EOHILIA™
EOHILIA™ (budesonide oral suspension) is an FDA approved 12-week oral treatment for EoE in people 11 years and older. It has not been shown to be safe and effective for longer than 12 weeks. Website for U.S. residents only. See Important Safety Information and Prescribing Information.
Key Topics
Details
Category: Healthcare
eohilia.comAI Visibility Breakdown
2
Structured Data
8
Content Structure
7
Entity Clarity
4
E-E-A-T Signals
7
Technical AEO
2
AI Discoverability
Is this your brand?
Claim your free page to manage and improve your AI visibility score.
Trust Is the Product. AI Is How You Build It at Scale.
In health and wellness, you're not just selling a product. You're asking someone to trust you with their body.
Continue reading in your free Engagemii portalFree signup unlocks the full article plus your personalized AEO fix list for EOHILIA™.
Source & Attribution
Scored by Engagemii on June 2, 2026. Methodology: engagemii.com/aeo/methodology
Source URL: https://engagemii.com/aeo/brands/eohilia
Cite this score: Engagemii (2026). "AEO Score for EOHILIA™." Retrieved from https://engagemii.com/aeo/brands/eohilia
Licensed under CC BY 4.0. You may reuse this data with attribution: a visible link to engagemii.com.
Powered by Engagemii - AI Brand Discovery and AEO Platform